Unchained Labs just couldn’t take it anymore, frees the Big Kahuna!

August 20, 2018 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, renamed its flagship workflow solution today. Freeslate is now the Big Kahuna. “We really love this product and it deserved to be a part of the Unchained Labs family,” said Taegen Clary, VP... Read more

Tecan accelerates broad genomics strategy with the acquisition of NuGEN Technologies

August 16, 2018 Acquisition of US-based NuGEN expands Tecan’s dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits and genomic sample prep reagents for the fastest growing field within the genomics area NuGEN to become part of Tecan’s Life Sciences Business, leveraging Tecan’s... Read more

Gyros Protein Technologies introduces Gyrolab CHO-HCP E3G Kit for impurity testing of biotherapeutics

Incorporates Cygnus Technologies’ gold standard reagents Ready-to-use immunoassay kit designed to increase productivity Uppsala, Sweden, 13 August 2018 Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls) – bioprocess workflow of biotherapeutics.... Read more

New Phadia 200 Advances In-vitro Diagnostics in Europe for Allergy and Autoimmune Conditions

CHICAGO – AACC – (July 31, 2018) – A new benchtop instrument from Thermo Fisher Scientific, the Phadia 200, enables new levels of flexibility and automation for laboratory testing facilities to aid in the diagnosis of allergy and autoimmunity conditions. The Phadia 200 is CE-marked, and the first installations are underway at select European sites.... Read more

QIAGEN and Hamilton launch new collaboration to improve pre-analytical sample processing for QuantiFERON-TB Gold Plus

Germantown, Maryland, Hilden, Germany, and Reno, Nevada, July 30, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Hamilton Robotics, a privately held leader in automation and liquid handling technology, today announced a new collaboration to improve processing of QIAGEN’s QuantiFERON-TB Gold Plus (QFT-Plus) diagnostic test through the integration of Hamilton’s Microlab® STAR™... Read more

OMNIS Sample Robot – maximizing throughput on the titration bench

7/30/2018 Breaking the limits of all existing automation solutions: The OMNIS Sample Robot addresses the need of large QC laboratories in the manufacturing industries as well as contract laboratories for an efficient solution to cope with high sample loads at the lowest possible cost per sample. Entirely modular by design, the OMNIS Sample Robot benefits users with unique... Read more

PerkinElmer’s EUROIMMUN Receives FDA Clearance for ANCA IFA and EUROPLUS Granulocyte Mosaic™ assays using EUROPattern Microscope

Assist in Screening and Diagnosing ANCA-Associated Vasculitis WALTHAM, Mass. – July 25, 2018 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN ANCA IFA and EUROPLUS Granulocyte Mosaic™ assays for use with EUROPattern microscope have received 510(k) clearance from the U.S. Food & Drug Administration (FDA).... Read more

Labcyte to Support GP-write Project Under New Agreement with Center of Excellence for Engineering Biology

Researchers Will Receive Preferred Pricing and Early Access to New Technologies for Understanding the Blueprint for Life Provided by the Human Genome Project (HGP-read) July 17, 2018 SAN JOSE, California Labcyte Inc. today announced an agreement with the Center for Excellence in Engineering Biology (CEEB), an independent nonprofit that is managing initial planning and coordination... Read more

Gyros Protein Technologies and Cygnus Technologies sign licensing and supply agreement

Uppsala, Sweden and Southport, N.C., July 10, 2018: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaceuticals, today announced they have signed a licensing and supply agreement. Under the... Read more